Cipargamin

DB12306InvestigationalSmall molecule

Cipargamin has been used in trials studying the treatment of Malaria, Cure Rate, and Plasmodium Falciparum Malaria.

Chemical structure of Cipargamin
Formula / weight
C19H14Cl2FN3O · 390.24 g/mol (avg)
Code names
KAE-609 · NITD-609

Resolves to

Compound
UNIIZ7Q4FWA04PCAS1193314-23-6ChEMBLCHEMBL1082723PubChem44469321
Structure
InChIKeyCKLPLPZSUQEDRT-WPCRTTGESA-NSMILESC[C@H]1CC2=C(NC3=CC(Cl)=C(F)C=C23)[C@@]2(N1)C(=O)NC1=CC=C(Cl)C=C21
Targets
Q12809KCNH2P0DMS8ADORA3

What you can answer from here — as of January 29, 2025

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
7Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Cipargamin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In